Early dysfunction of central 5-HT system in a murine model of bovine spongiform encephalopathy

Neuroscience

Volumn 160, Issue 4, 2009, Pages 731-743

  Vidal, C ^a,b,c   Herzog, C ^c   Haeberle, A M ^d   Bombarde, C ^d   Miquel, M C ^e   Carimalo, J ^e   Launay, J M ^f   Mouillet Richard, S ^a,b   Lasmezas C ^c,g   Dormont, D ^c   Kellermann, O ^a,b   Bailly, Y ^d  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

^c INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^d Hopitaux Universitaires de Strasbourg   (France)

^e CNRS   (France)

^f HÔPITAL LARIBOISIÈRE   (France)

^g SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

5 HT; BSE; neurodegenerative disease; prion; raphe; suprachiasmatic nucleus

Indexed keywords

PRION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR CHANGE; BRAIN SPONGIOSIS; CIRCADIAN RHYTHM; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HOMEOSTASIS; HYPERALGESIA; LOCOMOTION; MOTOR PERFORMANCE; MOUSE; NEOCORTEX; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; RAPHE NUCLEUS; SEROTONINERGIC SYSTEM;

ANIMALS; ANXIETY DISORDERS; BRAIN; BRAIN STEM; CATTLE; CHRONOBIOLOGY DISORDERS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENCEPHALOPATHY, BOVINE SPONGIFORM; FEMALE; HOMEOSTASIS; MENTAL DISORDERS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; PAIN; PRPC PROTEINS; PRPSC PROTEINS; RAPHE NUCLEI; SEROTONIN; SEROTONIN SYNDROME; TIME FACTORS;

EID: 64849093666     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.02.072     Document Type: Article

References (76)

1. Andrade T.G., Macedo C.E., Zangrossi Jr. H., and Graeff F.G. Anxiolytic-like effects of median raphe nucleus lesion in the elevated T-maze. Behav Brain Res 153 (2004) 55-60
2. Bareggi S.R., Braida D., Gervasoni M., Carcassola G., Pollera C., Verzoni C., Sala M., and Vergerio C. Neurochemical and behavioural modifications induced by scrapie infection in golden hamsters. Brain Res 984 (2003) 237-241
3. Bassant M.H., Court L., and Cathala F. Impairment of the cortical and thalamic electrical activity in scrapie-infected rats. Electroencephalogr Clin Neurophysiol 66 (1987) 307-316
4. Bassant M.H., Fage D., Dedek J., Cathala F., Court L., and Scatton B. Monoamine abnormalities in the brain of scrapie-infected rats. Brain Res 308 (1984) 182-185
5. Bassant M.H., Picard M., Olichon D., Cathala F., and Court L. Changes in the serotonergic, noradrenergic and dopaminergic levels in the brain of scrapie-infected rats. Brain Res 367 (1986) 360-363
6. Baumgarten H.G., and Lachenmayer L. Serotonin neurotoxins-past and present. Neurotox Res 6 (2004) 589-614
7. Bill D.J., Knight M., Forster E.A., and Fletcher A. Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia. Br J Pharmacol 103 (1991) 1857-1864
8. Briley M., Chopin P., and Moret C. Effect of serotonergic lesion on "anxious" behaviour measured in the elevated plus-maze test in the rat. Psychopharmacology (Berl) 101 (1990) 187-189
9. Bueler H., Fischer M., Lang Y., Bluethmann H., Lipp H.P., DeArmond S.J., Prusiner S.B., Aguet M., and Weissmann C. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356 (1992) 577-582
10. Coitinho A.S., Roesler R., Martins V.R., Brentani R.R., and Izquierdo I. Cellular prion protein ablation impairs behavior as a function of age. Neuroreport 14 (2003) 1375-1379
11. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24 (2001) 519-550
12. Cools R., Roberts A.C., and Robbins T.W. Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn Sci 12 (2008) 31-40
13. Cortelli P., Polinsky R., Montagna P., and Lugaresi E. Alteration of the serotoninergic system in fatal familial insomnia. Ann Neurol 50 (2001) 421-422
14. Costall B., Jones B.J., Kelly M.E., Naylor R.J., and Tomkins D.M. Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol Biochem Behav 32 (1989) 777-785
15. Crawley J.N. Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacol Biochem Behav 15 (1981) 695-699
16. Cross A.J., Kimberlin R.H., Crow T.J., Johnson J.A., and Walker C.A. Neurotransmitter metabolites, enzymes and receptors in experimental scrapie. J Neurol Sci 70 (1985) 231-241
17. Dell'Omo G., Vannoni E., Vyssotski A.L., Di Bari M.A., Nonno R., Agrimi U., and Lipp H.P. Early behavioural changes in mice infected with BSE and scrapie: automated home cage monitoring reveals prion strain differences. Eur J Neurosci 16 (2002) 735-742
18. Eide P.K., Berge O.G., Tjolsen A., and Hole K. Apparent hyperalgesia in the mouse tail-flick test due to increased tail skin temperature after lesioning of serotonergic pathways. Acta Physiol Scand 134 (1988) 413-420
19. Fraser H., and Dickinson A.G. The sequential development of the brain lesion of scrapie in three strains of mice. J Comp Pathol 78 (1968) 301-311
20. Goodwin G.M., De Souza R.J., and Green A.R. Presynaptic serotonin receptor-mediated response in mice attenuated by antidepressant drugs and electroconvulsive shock. Nature 317 (1985) 531-533
21. Goodwin G.M., De Souza R.J., and Green A.R. The effects of a 5-HT1 receptor ligand isapirone (TVX Q 7821) on 5-HT synthesis and the behavioural effects of 5-HT agonists in mice and rats. Psychopharmacology (Berl) 89 (1986) 382-387
22. Goudsmit J., Rohwer R.G., Silbergeld E.K., and Gajdusek D.C. Hypersensitivity to central serotonin receptor activation in scrapie-infected hamsters and the effect of serotonergic drugs on scrapie symptoms. Brain Res 220 (1981) 372-377
23. Guentchev M., Voigtlander T., Haberler C., Groschup M.H., and Budka H. Evidence for oxidative stress in experimental prion disease. Neurobiol Dis 7 (2000) 270-273
24. Guenther K., Deacon R.M., Perry V.H., and Rawlins J.N. Early behavioural changes in scrapie-affected mice and the influence of dapsone. Eur J Neurosci 14 (2001) 401-409
25. Hamon M. Neuropharmacology of anxiety: perspectives and prospects. Trends Pharmacol Sci 15 (1994) 36-39
26. Harrison A.A., Everitt B.J., and Robbins T.W. Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms. Psychopharmacology (Berl) 133 (1997) 329-342
27. Harrison A.A., Everitt B.J., and Robbins T.W. Central serotonin depletion impairs both the acquisition and performance of a symmetrically reinforced go/no-go conditional visual discrimination. Behav Brain Res 100 (1999) 99-112
28. Heitz S., Lutz Y., Rodeau J.L., Zanjani H., Gautheron V., Bombarde G., Richard F., Fuchs J.P., Vogel M.W., Mariani J., and Bailly Y. BAX contributes to doppel-induced apoptosis of prion-protein-deficient Purkinje cells. Dev Neurobiol 67 (2007) 670-686
29. Henry C., Lowman A., and Will R.G. Creutzfeldt-Jakob disease in elderly people. Age Ageing 31 (2002) 7-10
30. Herzog C., Sales N., Etchegaray N., Charbonnier A., Freire S., Dormont D., Deslys J.P., and Lasmezas C.I. Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection. Lancet 363 (2004) 422-428
31. Jouvet M. Sleep and serotonin: an unfinished story. Neuropsychopharmacology 21 (1999) 24S-27S
32. Keshet G.I., Ovadia H., Taraboulos A., and Gabizon R. Scrapie-infected mice and PrP knockout mice share abnormal localization and activity of neuronal nitric oxide synthase. J Neurochem 72 (1999) 1224-1231
33. Kim Y.S., Carp R.I., Callahan S.M., and Wisniewski H.M. Incubation periods and survival times for mice injected stereotaxically with three scrapie strains in different brain regions. J Gen Virol 68 Pt 3 (1987) 695-702
34. Klamt F., Dal-Pizzol F., Conte da Frota M.J., Walz R., Andrades M.E., da Silva E.G., Brentani R.R., Izquierdo I., and Fonseca Moreira J.C. Imbalance of antioxidant defense in mice lacking cellular prion protein. Free Radic Biol Med 30 (2001) 1137-1144
35. Kloppel S., Pirker W., Brucke T., Kovacs G.G., and Almer G. Beta-CIT SPECT demonstrates reduced availability of serotonin transporters in patients with fatal familial insomnia. J Neural Transm 109 (2002) 1105-1110
36. Kofman O., Levin U., and Alpert C. Lithium attenuates hypokinesia induced by immobilization stress in rats. Prog Neuropsychopharmacol Biol Psychiatry 19 (1995) 1081-1090
37. Lasmezas C.I., Deslys J.P., Demaimay R., Adjou K.T., Hauw J.J., and Dormont D. Strain specific and common pathogenic events in murine models of scrapie and bovine spongiform encephalopathy. J Gen Virol 77 Pt 7 (1996) 1601-1609
38. Le Bars D., Gozariu M., and Cadden S.W. Animal models of nociception. Pharmacol Rev 53 (2001) 597-652
39. Le Moal M., and Simon H. Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol Rev 71 (1991) 155-234
40. Lin P.Y.T., Bulawa M.C., Wong P., Lin L., Scott J., and Blank C.L. The determination of catecholamines, indoleamines, metabolites, and related enzyme activities using three micron liquid chromatography columns. J Liq Chromatogr 7 (1984) 509-538
41. Llewelyn C.A., Hewitt P.E., Knight R.S., Amar K., Cousens S., Mackenzie J., and Will R.G. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363 (2004) 417-421
42. Lobao-Soares B., Walz R., Carlotti Jr. C.G., Sakamoto A.C., Calvo F., Terzian A.L., da Silva J.A., Wichert-Ana L., Coimbra N.C., and Bianchin M.M. Cellular prion protein regulates the motor behaviour performance and anxiety-induced responses in genetically modified mice. Behav Brain Res 183 (2007) 87-94
43. Lynn D.E. A BASIC computer program for analyzing endpoint assays. BioTechniques 12 (1992) 880-881
44. Mallucci G., Dickinson A., Linehan J., Klohn P.C., Brandner S., and Collinge J. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302 (2003) 871-874
45. Mallucci G.R., White M.D., Farmer M., Dickinson A., Khatun H., Powell A.D., Brandner S., Jefferys J.G., and Collinge J. Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron 53 (2007) 325-335
46. McNaughton N., and Gray J.A. Anxiolytic action on the behavioural inhibition system implies multiple types of arousal contribute to anxiety. J Affect Disord 61 (2000) 161-176
47. Meotti F.C., Carqueja C.L., Gadotti Vde M., Tasca C.I., Walz R., and Santos A.R. Involvement of cellular prion protein in the nociceptive response in mice. Brain Res 1151 (2007) 84-90
48. Millan M.J. Descending control of pain. Prog Neurobiol 66 (2002) 355-474
49. Millan M.J. The neurobiology and control of anxious states. Prog Neurobiol 70 (2003) 83-244
50. Morin L.P., and Blanchard J. Depletion of brain serotonin by 5,7-DHT modifies hamster circadian rhythm response to light. Brain Res 566 (1991) 173-185
51. Mouillet-Richard S., Nishida N., Pradines E., Laude H., Schneider B., Feraudet C., Grassi J., Launay J.M., Lehmann S., and Kellermann O. Prions impair bioaminergic functions through serotonin- or catecholamine-derived neurotoxins in neuronal cells. J Biol Chem 283 (2008) 23782-23790
52. Mouillet-Richard S., Pietri M., Schneider B., Vidal C., Mutel V., Launay J.M., and Kellermann O. Modulation of serotonergic receptor signaling and Cross-talk by prion protein. J Biol Chem 280 (2005) 4592-4601
53. Murrough J.W., Boss-Williams K.A., Emery M.S., Bonsall R.W., and Weiss J.M. Depletion of brain norepinephrine does not reduce spontaneous ambulatory activity of rats in the home cage. Brain Res 883 (2000) 125-130
54. Nico P.B., de-Paris F., Vinade E.R., Amaral O.B., Rockenbach I., Soares B.L., Guarnieri R., Wichert-Ana L., Calvo F., Walz R., Izquierdo I., Sakamoto A.C., Brentani R., Martins V.R., and Bianchin M.M. Altered behavioural response to acute stress in mice lacking cellular prion protein. Behav Brain Res 162 (2005) 173-181
55. Olausson P., Akesson P., Petersson A., Engel J.A., and Soderpalm B. Behavioral and neurochemical consequences of repeated nicotine treatment in the serotonin-depleted rat. Psychopharmacology (Berl) 155 (2001) 348-361
56. Ovadia H., Rosenmann H., Shezen E., Halimi M., Ofran I., and Gabizon R. Effect of scrapie infection on the activity of neuronal nitric-oxide synthase in brain and neuroblastoma cells. J Biol Chem 271 (1996) 16856-16861
57. Prusiner S.B. Prions. Proc Natl Acad Sci U S A 95 (1998) 13363-13383
58. Rasenick M.M., Valley S., Manuelidis E.E., and Manuelidis L. Creutzfeldt-Jakob infection increases adenylate cyclase activity in specific regions of guinea pig brain. FEBS Lett 198 (1986) 164-168
59. Robbins T.W. Dopamine and cognition. Curr Opin Neurol 16 Suppl 2 (2003) S1-S2
60. Roesler R., Walz R., Quevedo J., de-Paris F., Zanata S.M., Graner E., Izquierdo I., Martins V.R., and Brentani R.R. Normal inhibitory avoidance learning and anxiety, but increased locomotor activity in mice devoid of PrP(C). Brain Res Mol Brain Res 71 (1999) 349-353
61. Rohwer R.G., Neckers L.M., Trepel J.B., Gajdusek D.C., and Wyatt R.J. Serotonin concentrations in brain and blood of scrapie-infected and normal hamsters and mice. Brain Res 220 (1981) 367-371
62. Sanchez-Alavez M., Conti B., Moroncini G., and Criado J.R. Contributions of neuronal prion protein on sleep recovery and stress response following sleep deprivation. Brain Res 1158 (2007) 71-80
63. Schneider B., Mutel V., Pietri M., Ermonval M., Mouillet-Richard S., and Kellermann O. NADPH oxidase and extracellular regulated kinases 1/2 are targets of prion protein signaling in neuronal and nonneuronal cells. Proc Natl Acad Sci U S A 100 (2003) 13326-13331
64. Smale L., Michels K.M., Moore R.Y., and Morin L.P. Destruction of the hamster serotonergic system by 5,7-DHT: effects on circadian rhythm phase, entrainment and response to triazolam. Brain Res 515 (1990) 9-19
65. Spencer M.D., Knight R.S., and Will R.G. First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features. BMJ 324 (2002) 1479-1482
66. Steele A.D., Jackson W.S., King O.D., and Lindquist S. The power of automated high-resolution behavior analysis revealed by its application to mouse models of Huntington's and prion diseases. Proc Natl Acad Sci U S A 104 (2007) 1983-1988
67. Tobler I., Deboer T., and Fischer M. Sleep and sleep regulation in normal and prion protein-deficient mice. J Neurol Sci 17 (1997) 1869-1879
68. Tobler I., Gaus S.E., Deboer T., Achermann P., Fischer M., Rulicke T., Moser M., Oesch B., McBride P.A., and Manson J.C. Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 380 (1996) 639-642
69. Tsiroulnikov K., Rezai H., Bonch-Osmolovskaya E., Nedkov P., Gousterova A., Cueff V., Godfroy A., Barbier G., Metro F., Chobert J.M., Clayette P., Dormont D., Grosclaude J., and Haertle T. Hydrolysis of the amyloid prion protein and nonpathogenic meat and bone meal by anaerobic thermophilic prokaryotes and Streptomyces subspecies. J Agric Food Chem 52 (2004) 6353-6360
70. Vidal C., Meric P., Provost F., Herzog C., Lasmezas C., Gillet B., Beloeil J.C., and Dormont D. Preclinical metabolic changes in mouse prion diseases detected by 1H-nuclear magnetic resonance spectroscopy. Neuroreport 17 (2006) 89-93
71. Wanschitz J., Kloppel S., Jarius C., Birner P., Flicker H., Hainfellner J.A., Gambetti P., Guentchev M., and Budka H. Alteration of the serotonergic nervous system in fatal familial insomnia. Ann Neurol 48 (2000) 788-791
72. Will R.G., Ironside J.W., Zeidler M., Cousens S.N., Estibeiro K., Alperovitch A., Poser S., Pocchiari M., Hofman A., and Smith P.G. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347 (1996) 921-925
73. Wong B.S., Liu T., Li R., Pan T., Petersen R.B., Smith M.A., Gambetti P., Perry G., Manson J.C., Brown D.R., and Sy M.S. Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein. J Neurochem 76 (2001) 565-572
74. Yun S.W., Choi E.K., Ju W.K., Ahn M.S., Carp R.I., Wisniewski H.M., and Kim Y.S. Extensive degeneration of catecholaminergic neurons to scrapie agent 87V in the brains of IM mice. Mol Chem Neuropathol 34 (1998) 121-132
75. Yun S.W., Gerlach M., Riederer P., and Klein M.A. Oxidative stress in the brain at early preclinical stages of mouse scrapie. Exp Neurol 201 (2006) 90-98
76. Zeidler M., Johnstone E.C., Bamber R.W., Dickens C.M., Fisher C.J., Francis A.F., Goldbeck R., Higgo R., Johnson-Sabine E.C., Lodge G.J., McGarry P., Mitchell S., Tarlo L., Turner M., Ryley P., and Will R.G. New variant Creutzfeldt-Jakob disease: psychiatric features. Lancet 350 (1997) 908-910